Bill · S. 3729· Senate(119-S-3729)
PBM Reporting Transparency Act
- Introduced
- 1/29/2026
- Last activity
- 1/29/2026 — Read twice and referred to the Committee on Finance.
- Sponsored by
- Mark Warner
- Cosponsors
- - 1 - 2
- Introduced
- In Committee
What this bill would do
This bill, known as the "PBM Reporting Transparency Act," requires the Medicare Payment Advisory Commission (MedPAC) to submit two specific reports to Congress. These reports focus on agreements with pharmacy benefit managers regarding prescription drug plans and MA-PD plans. The first report must include descriptions of trends, patterns, and an analysis of how agreements affect enrollee out-of-pocket spending and pharmacy reimbursement. The second report must describe changes over time. Both reports allow for recommendations from the Commission.
Yes· 3 of 7
Does this make what the government does easier for the public to see?+5
The bill increases transparency by requiring MedPAC to report on the trends and impacts of agreements made by pharmacy benefit managers.
Would people over 65 be better off under this?+3
The bill benefits seniors by analyzing how drug plan agreements affect their out-of-pocket costs under Medicare.
Would retired people be better off under this?+3
The bill provides oversight into Medicare drug plan costs which directly impacts the financial well-being of retirees.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Transparency on Spending: The initial report requires an analysis of how agreements affect plan enrollee out-of-pocket spending (Section 2, Paragraph 1, Subparagraph B). This could help people understand how these agreements impact their personal costs.
-
Insight into Pharmacy Reimbursement: The bill requires a description of the effects of agreements on average pharmacy reimbursement (Section 2, Paragraph 1, Subparagraph B). This provides a look at how these agreements impact the pharmacy industry.
-
Identification of Trends: The report requires a description of trends and patterns, including averages and totals (Section 2, Paragraph 1, Subparagraph A). This provides a clear picture of how these agreements are evolving.
-
Expert Recommendations: The Commission is empowered to provide any recommendations it determines are appropriate (Section 2, Paragraph 1, Subparagraph C and Paragraph 2). This allows for expert suggestions to be presented to Congress.
Potential Negative Impacts for People
- No specific negative impacts are mentioned in the text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+3Good For Seniors+3Good For Low Income Households+2Good For Veterans+2
- Governance And Ideology
- Improves Government Transparency+5
- Economy And Finance
- Improves Consumer Protection+3
- Healthcare
- Reduces Prescription Drug Costs+2
- 1/29/2026
- Read twice and referred to the Committee on Finance.
- 3 Cosponsors added.
- Introduced in Senate
Catherine Cortez MastoDemocrat · Nevada
Roger MarshallRepublican · Kansas
Thomas TillisRepublican · North Carolina